Reply to 'Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation'.
作者信息
Verheul Lisa M, Hassink Rutger J
机构信息
Department of Cardiology, UMC Utrecht, Utrecht, The Netherlands.
出版信息
Neth Heart J. 2024 Oct;32(10):366. doi: 10.1007/s12471-024-01899-z. Epub 2024 Sep 9.
Abstract
摘要
相似文献
1
Reply to 'Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation'.对《特发性室颤患者未必均需植入式心脏复律除颤器》一文的回复
Neth Heart J. 2024 Oct;32(10):366. doi: 10.1007/s12471-024-01899-z. Epub 2024 Sep 9.
2
Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.无明显结构性心脏病患者的心室颤动：植入式心脏复律除颤器治疗的多中心经验
J Am Coll Cardiol. 1993 May;21(6):1406-12. doi: 10.1016/0735-1097(93)90317-t.
3
Implantable cardioverter defibrillator during laser transurethral resection of the prostate.前列腺激光经尿道切除术期间的植入式心脏复律除颤器
Heart Lung Vessel. 2014;6(1):60-4.
4
Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation.对于所有特发性室颤患者而言，植入式心脏复律除颤器可能并非必要。
Neth Heart J. 2024 Oct;32(10):365. doi: 10.1007/s12471-024-01898-0. Epub 2024 Sep 6.
5
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.胸壁单极植入式心脏复律除颤器的多中心经验。主动除颤电极导线研究者。
J Am Coll Cardiol. 1996 Aug;28(2):400-10.
6
Implantable cardioverter-defibrillator: present and future indications.植入式心脏复律除颤器：当前及未来的适应症
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
7
Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.特发性室颤患者植入式心脏转复除颤器治疗及其并发症的发生率和预测因素。
Europace. 2019 Oct 1;21(10):1519-1526. doi: 10.1093/europace/euz151.
8
Impact of the implantable cardioverter-defibrillator on rehospitalizations.植入式心脏复律除颤器对再次住院的影响。
Eur Heart J. 1996 Oct;17(10):1565-71. doi: 10.1093/oxfordjournals.eurheartj.a014722.
9
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
10
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.肥厚型心肌病中的植入式心脏复律除颤器
Rev Port Cardiol. 2005 Mar;24(3):407-15.
本文引用的文献
1
The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable.荷兰特发性心室颤动注册研究：识别难以识别者的进展报告
Neth Heart J. 2024 Jun;32(6):238-244. doi: 10.1007/s12471-024-01870-y. Epub 2024 Apr 23.
2
Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death.不明原因室性心律失常患者心脏性猝死二级预防中合适的植入式心律转复除颤器治疗
J Clin Med. 2023 Jul 4;12(13):4479. doi: 10.3390/jcm12134479.
3
Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation: Results From the Dutch iVF Registry.系统性诊断测试在特发性心室颤动中的重要性：来自荷兰特发性心室颤动注册研究的结果
JACC Clin Electrophysiol. 2023 Mar;9(3):345-355. doi: 10.1016/j.jacep.2022.10.003. Epub 2022 Nov 30.
Zotero 插件